Novo Nordisk, maker of weight-loss drug Wegovy, struck a deal with online telehealth storefronts that sold cheap knockoffs during shortages.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
Gucci’s parent company expects sales to slump by 10%, largely due to a downturn in Chinese demand.
The international consumer giant has decided that an entire ice cream portfolio has just become too costly.
The British car maker said seven out of 10 customers spent more than $43,000 on customizing their new rides.
Reducing beverage-wait times is part of Starbucks CEO Brian Niccol’s turnaround plan, which includes tech updates focused on efficiency.
Why is Saudi Arabia spending a king’s ransom on sports? The Middle East powerhouse doesn’t care if you call it sportswashing.
The energy titan has extended the timeline for its plan to reduce its “carbon intensity.”
Despite tariffs, the US imported a record number of panels through November of last year.
To prepare for a slowdown of global trade, US retailers spent months building a massive inventory to prevent empty shelves.
Southwest and Alaska said that the manufacturer’s uncertain status makes it hard to forecast the year ahead.
The vacation rental company is ramping up privacy as it continues to battle customer satisfaction issues.
Bioprospecting for genes of new species in the world’s oceans has become complex and extremely lucrative.
Canada’s Liberal Party won a majority promising to distance the country from the US, a major importer of Canadian crude.
Investor worries about a fresh batch of US tariffs have dragged LVMH shares in Paris down 23.6% so far this year.
The company plans to seek regulatory approval for the revolutionary weight loss treatment by the end of the year.
The warnings come as the industry adapts to seismic shifts in technology — which means it may just have some new tricks up its sleeve.